CDKN2A is a tumor suppressor located in chromosome 9p21 and frequently lost in Barrett’s esophagus (BE) and esophageal adenocarcinoma (EAC). How CDKN2A and other 9p21 gene co-deletions affect EAC evolution remains understudied. We explored the effects of 9p21 loss in EACs and cancer progressor and non-progressor BEs with matched genomic, transcriptomic and clinical data. Despite its cancer driver role, CDKN2A loss in BE prevents EAC initiation by counterselecting subsequent TP53 alterations. 9p21 gene co-deletions predict poor patient survival in EAC but not BE through context-dependent effects on cell cycle, oxidative phosphorylation and interferon response. Immune quantifications using bulk transcriptome, RNAscope and high-dimensional tissue imaging showed that IFNE loss reduces immune infiltration in BE, but not EAC. Mechanistically, CDKN2A loss suppresses the maintenance of squamous epithelium, contributing to a more aggressive phenotype. Our study demonstrates context-dependent roles of cancer genes during disease evolution, with consequences for cancer detection and patient management.
Context-dependent effects of CDKN2A and other 9p21 gene losses during the evolution of esophageal cancer / P. Ganguli, C.C. Basanta, A. Acha-Sagredo, H. Misetic, M. Armero, A. Mendez, A. Zahra, G. Devonshire, G. Kelly, A. Freeman, M. Green, E. Nye, A. Bichisecchi, P. Bonfanti, N. Null, R.C. Fitzgerald, P.A.W. Edwards, N. Grehan, B. Nutzinger, A.M. Redmond, C. Loreno, S. Abbas, A. Freeman, E.C. Smyth, M. O'Donovan, A. Miremadi, S. Malhotra, M. Tripathi, H. Coles, C. Millington, M. Eldridge, M. Secrier, G. Devonshire, J. Davies, C. Crichton, N. Carroll, R.H. Hardwick, P. Safranek, A. Hindmarsh, V. Sujendran, S.J. Hayes, Y. Ang, A. Sharrocks, S.R. Preston, I. Bagwan, V. Save, R.J.E. Skipworth, T.R. Hupp, J.R. O'Neill, O. Tucker, A. Beggs, P. Taniere, S. Puig, G. Contino, T.J. Underwood, R.C. Walker, B.L. Grace, J. Lagergren, J. Gossage, A. Davies, F. Chang, U. Mahadeva, V. Goh, F.D. Ciccarelli, G. Sanders, R. Berrisford, D. Chan, E. Cheong, B. Kumar, L. Sreedharan, S.L. Parsons, I. Soomro, P. Kaye, J. Saunders, L. Lovat, R. Haidry, M. Scott, S. Sothi, S. Lishman, G.B. Hanna, C.J. Peters, K. Moorthy, A. Grabowska, R. Turkington, D. Mcmanus, H. Coleman, R.D. Petty, F. Bartlett, M. Rodriguez-Justo, J. Spencer, R.C. Fitzgerald, F.D. Ciccarelli. - In: NATURE CANCER. - ISSN 2662-1347. - 6:1(2025 Jan 03), pp. 35.158-35.174. [10.1038/s43018-024-00876-0]
Context-dependent effects of CDKN2A and other 9p21 gene losses during the evolution of esophageal cancer
G. Contino;F.D. Ciccarelli;F.D. Ciccarelli
Ultimo
Conceptualization
2025
Abstract
CDKN2A is a tumor suppressor located in chromosome 9p21 and frequently lost in Barrett’s esophagus (BE) and esophageal adenocarcinoma (EAC). How CDKN2A and other 9p21 gene co-deletions affect EAC evolution remains understudied. We explored the effects of 9p21 loss in EACs and cancer progressor and non-progressor BEs with matched genomic, transcriptomic and clinical data. Despite its cancer driver role, CDKN2A loss in BE prevents EAC initiation by counterselecting subsequent TP53 alterations. 9p21 gene co-deletions predict poor patient survival in EAC but not BE through context-dependent effects on cell cycle, oxidative phosphorylation and interferon response. Immune quantifications using bulk transcriptome, RNAscope and high-dimensional tissue imaging showed that IFNE loss reduces immune infiltration in BE, but not EAC. Mechanistically, CDKN2A loss suppresses the maintenance of squamous epithelium, contributing to a more aggressive phenotype. Our study demonstrates context-dependent roles of cancer genes during disease evolution, with consequences for cancer detection and patient management.| File | Dimensione | Formato | |
|---|---|---|---|
|
unpaywall-bitstream-256009674.pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Licenza:
Creative commons
Dimensione
5.24 MB
Formato
Adobe PDF
|
5.24 MB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.




